94864 ⎘
Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
COMPOUNDS, DEVICES, AND USES THEREOF
#2C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#3COMPOSITIONS AND METHODS FOR INDUCING FERROPTOSIS
#4Prodrugs of Fumarates and Their Use in Treating Various Diseases
#5NANOMATERIALS
#6Olfactory Delivery Scaffolds Using Antisense Oligonucleotides and Methods for Making and Using Same
#7Charged Ion Channel Blockers and Methods for Use
#8"Good" buffer-based cationic lipids
#9CATIONIC LIPID, LIPOSOME, LIPID NANOPARTICLE, AND USE
#10METHOD OF INHIBITING TAU PHOSPHORYLATION
#11POLYMORPH FORM OF PITOLISANT HYDROCHLORIDE
#12Prodrugs of Fumarates and Their Use in Treating Various Diseases
#13BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
#14METHOD OF INHIBITING TAU PHOSPHORYLATION
#15SOLID FORMS OF 1-{3-[3-(4-CHLOROPHENYL) PROPOXY] PROPYL} PIPERIDINE HYDROCHLORIDE AND PROCESS FOR THE PREPARATION THEREOF
#16C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#17COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF
#18HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#19ACRYLATE DERIVATIVE, USE AND PRODUCTION INTERMEDIATE COMPOUND OF THE SAME
#20ACRYLATE DERIVATIVE, USE AND PRODUCTION INTERMEDIATE COMPOUND OF THE SAME
#21N-SUBSTITUTED C6 CYCLYL CARBOXAMIDE COMPOUNDS AND USES THEREOF
#22Polymorph form of pitolisant hydrochloride
#23Prodrugs of Fumarates and Their Use in Treating Various Diseases
#24IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES
#25TREPROSTINIL DERIVATIVE COMPOUNDS AND METHODS OF USING SAME
#26COMPOUNDS, DEVICES, AND USES THEREOF
#27"Good" buffer-based cationic lipids
#282-METHYLENE-4-OXO-BUTANOIC ACID DERIVATIVES FOR THE TREATMENT OF INFLAMMATION
#29CHIRAL CONTROL
#30AMINE COMPOUND, CHEMICALLY AMPLIFIED RESIST COMPOSITION AND PATTERNING PROCESS
#31COMPOUNDS WITH CLEAVABLE DISULFIDE MOIETIES
#32METHOD OF INHIBITING TAU PHOSPHORYLATION
#33INHIBITORS OF THE WNT/BETA-CATENIN PATHWAY
#34Prodrugs of fumarates and their use in treating various diseases
#35CYCLOPROPENIUM COMPOUNDS, PROCESS FOR THEIR PREPARATION AND USE
#36Treprostinil derivative compounds and methods of using same
#37IONIZABLE CATIONIC LIPIDS AND LIPID NANOPARTICLES
#38NOVEL AMINO ACID DERIVATIVES
#39HIGH PENETRATION COMPOSITIONS AND THEIR APPLICATIONS
#40Process for preparing pitolisant hydrochloride and solid-state forms thereof
#41PLATINUM COMPOUNDS THAT INHIBIT CONSTITUTIVE STAT3 SIGNALING AND INDUCE CELL CYCLE ARREST AND APOPTOSIS OF MALIGNANT CELLS
#42PHENOLIC ACID LIPID BASED CATIONIC LIPIDS
#43C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#44SUBSTITUTED IMIDAZOLE CARBOXAMIDES AND THEIR USE IN THE TREATMENT OF MEDICAL DISORDERS
#45Process for preparing pitolisant hydrochloride and solid-state forms thereof
#46TYROSINE KINASE INHIBITOR COMPOSITIONS, METHODS OF MAKING AND METHODS OF USE
#47Prodrugs of fumarates and their use in treating various diseases
#48Fluorine-containing ether compound, lubricant for magnetic recording medium, and magnetic recording medium
#49SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#50HETEROCYCLIC COMPOUNDS FOR CANCER IMAGING AND TREATMENT AND METHODS FOR THEIR USE
#51ITACONIC ACID DERIVATIVES AND USES THEREOF INTREATING AN INFLAMMATORY DISEASE OR A DISEASE ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE
#52BROAD SPECTRUM ANTIVIRAL COMPOUNDS TARGETING THE SKI COMPLEX
#53Acrylate derivative, use and production intermediate compound of the same
#54Method for Preparation of Acetoacetate Ester Compounds
#55REACTIVE SURFACTANTS
#56Compound for modulating DDAH and ADMA levels, as well as methods of using thereof to treat disease
#57Treprostinil derivative compounds and methods of using same
#58APHTHYLAMINE COMPOUND AND BIOLOGICALLY ACCEPTABLE SALT THEREOF, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#59Prodrugs of fumarates and their use in treating various diseases
#60COMPOUNDS FOR THE INHIBITION OF UNREGULATED CELL GROWTH
#61Ammonium salt having saccharin anion
#62ADO-resistant cysteamine analogs and uses thereof
#63LOX INHIBITORS
#64SULFUR (VI) FLUORIDE COMPOUNDS AND METHODS FOR THE PREPARATION THEREOF
#65COMPOSITIONS AND METHODS FOR SUPPRESSING AND/OR TREATING METABOLIC DISEASES AND/OR A CLINICAL CONDITION THEREOF
#66Production of hydroxyethylpiperazine
#67Bisphenol derivatives and their use as androgen receptor activity modulators
#68Process for the synthesis of piperazinyl-ethoxy-bromophenyl derivates and their application in the production of compounds containing them
#69Inhibitors of the WNT/beta-catenin pathway
#70hTERT MODULATORS AND METHODS OF USE
#71PD-1/PD-L1 INHIBITORS
#72Charged ion channel blockers and methods for use
#73Resist composition and patterning process
#74Biological buffers with wide buffering ranges
#75Hepatitis B antiviral agents
#76POLYAMINO BIARYL COMPOUNDS AND THEIR USE
#77NANOMATERIALS
#78Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
#79Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
#80Tyrosine kinase inhibitor compositions, methods of making and methods of use
#81Biological buffers with wide buffering ranges
#82Immunomodulator compounds
#83Chiral control
#84Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#85Prodrugs of fumarates and their use in treating various diseases
#86C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#87Method of inhibiting tau phosphorylation
#88Lipids and lipid compositions for the delivery of active agents
#89Treprostinil derivative compounds and methods of using same
#90Sulfur (VI) fluoride compounds and methods for the preparation thereof
#91Perfluorinated 1-alkoxypropenes, compositions, and methods and apparatuses for using same
#92hTERT MODULATORS AND METHODS OF USE
#93Prodrugs of fumarates and their use in treating various diseases
#94Sulfonamide carboxamide compounds
#95Heterocyclic compounds for cancer imaging and treatment and methods for their use
#96Bisphenol derivatives and their use as androgen receptor activity modulators
#97Arylfluorosulfate compounds and methods
#98Hepatitis B antiviral agents
#99Compound used as autophagy regulator, and preparation method therefor and uses thereof
#100Derivatives of sobetirome
#101O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated with an accumulation of misfolded proteins
#102DNP and DNP prodrug treatment of neuromuscular, neurodegenerative, autoimmune, developmental, traumatic brain injury, concussion, dry eye disease, hearing loss and/or metabolic diseases
#103TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE
#104Biological buffers with wide buffering ranges
#105Treprostinil derivative compounds and methods of using same
#106C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#107Resist composition and patterning process
#108Crystalline binary sodium salts of 5-methyl-(6S)-tetrahydrofolic acid with organic bases
#109Compounds, devices, and uses thereof
#110Prodrugs of fumarates and their use in treating various diseases
#111PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES
#112Lipids and lipid compositions for the delivery of active agents
#113Treprostinil derivative compounds and methods of using same
#114Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
#115Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
#116Prodrugs of fumarates and their use in treating various diseases
#117Dual NAV1.2/5HT2a inhibitors for treating CNS disorders
#118Synthesis of sulfur containing ammonium and phosphonium borates
#119Fluorinated ionic liquids with high oxygen solubility for metal-air batteries
#120Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#121ARYLFLUOROSULFATE COMPOUNDS AND METHODS
#122PRO-DRUGS OF NSAIAS WITH VERY HIGH SKIN AND MEMBRANES PENETRATION RATES AND THEIR NEW MEDICINAL USES
#123Method of inhibiting tau phosphorylation
#124Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
#125Immunomodulator compounds
#126Hepatitis B antiviral agents
#127METHOD OF MODULATING RIBONUCLEOTIDE REDUCTASE
#128Preparation of ammonium or phosphonium borate salts
#129Sulfur(VI) fluoride compounds and methods for the preparation thereof
#130Process for stripping carbamate from ion exchange resin
#131C7-FLUORO SUBSTITUTED TETRACYCLINE COMPOUNDS
#132Nucleic acid-containing lipid nanoparticles
#133hTERT modulators and methods of use
#134Heterocyclic compounds for cancer imaging and treatment and methods for their use
#135PD-1/PD-L1 INHIBITORS
#136Lipids and lipid compositions for the delivery of active agents
#137Synthesis of copanlisib and its dihydrochloride salt
#138TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE
#139Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
#140Farnesoid X receptor agonists and uses thereof
#141HISTONE ACETYLTRANSFERASE MODULATORS AND USES THEREOF
#142TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE
#143ROR-gamma modulators and uses thereof
#144Process for making hydroxyethyl piperazine compounds
#145Treprostinil derivative compounds and methods of using same
#146Cationic lipid
#147Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#148Treprostinil derivative compounds and methods of using same
#149Fluorescent pI Markers for Isoelectric Focusing Separations and Fluorescent Labeling
#150Prodrugs of fumarates and their use in treating various diseases
#151Derivatives of sobetirome
#152Compounds useful as immunomodulators
#153SULFOBETAINE-CONTAINING DETERGENTS AND CLEANING AGENTS
#154Prodrugs of fumarates and their use in treating various diseases
#155Synthesis of sulfur containing ammonium and phosphonium borates
#156Prodrugs of fumarates and their use in treating various diseases
#157PHOTOACTIVATABLE CAGED TAMOXIFEN AND TAMOXIFEN DERIVATIVE MOLECULES AND METHODS OF USE THEREOF
#158Synthesis of copanlisib and its dihydrochloride salt
#159Biological Buffers with Wide Buffering Ranges
#160BISPHENOL DERIVATIVES AND THEIR USE AS ANDROGEN RECEPTOR ACTIVITY MODULATORS
#161Chiral control
#162Benzenesulfonyl-asymmetric ureas and medical uses thereof
#163C7-Fluoro Substituted Tetracycline Compounds
#164Biological Buffers with Wide Buffering Ranges
#165Hepatitis B antiviral agents
#166Traffic marking compositions containing polyfunctional amines
#167Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
#168Sulfur(VI) fluoride compounds and methods for the preparation thereof
#169DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
#170O-alkyl-benzylideneguanidine derivatives and therapeutic use for the treatment of disorders associated an accumulation of misfolded proteins
#171Modulators of the relaxin receptor 1
#172Histone acetyltransferase modulators and uses thereof
#173Treprostinil derivative compounds and methods of using same
#174TETRA-O-SUBSTITUTED BUTANE-BRIDGE MODIFIED NDGA DERIVATIVES, THEIR SYNTHESIS AND PHARMAECUTICAL USE
#175Use of reactive ionic liquids as additives for electrolytes in secondary lithium ion batteries
#176ADO-resistant cysteamine analogs and uses thereof
#177DYE COMPOSITION COMPRISING A CATIONIC PARA-AMINOPHENOL OXIDATION BASE
#178Biological Buffers with Wide Buffering Ranges
#179Treprostinil derivative compounds and methods of using same
#180Beta-amino ester gas hydrate inhibitors
#181AMIDOPHENOXYPROPANOLAMINES
#182N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#183Lipids and lipid compositions for the delivery of active agents
#184Lipids and lipid compositions for the delivery of active agents
#185NOVEL METABOLITES OF VANOXERINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS OF TERMINATING ACUTE EPISODES OF CARDIAC ARRHYTHMIA, RESTORING NORMAL SINUS RHYTHM, PREVENTING RECURRENCE OF CARDIAC ARRHYTHMIA AND MAINTAINING NORMAL SINUS RHYTHM IN MAMMALS
#186Aryl naphthyl methanone oxime(s) and process for preparation thereof
#187BIS-MMF derivatives
#188Pro-drugs of NSAIAs with very high skin and membranes penetration rates and their new medicinal uses
#189Derivatives of sobetirome
#190PRODRUGS OF MONOMETHYL FUMARATE (MMF)
#191Antibacterial compounds
#192Aniline derivatives, their preparation and their therapeutic application
#193PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES
#194Platinum compounds that inhibit constitutive STAT3 signaling and induce cell cycle arrest and apoptosis of malignant cells
#195Potent and selective inhibitors of monoamine transporters; method of making; and use thereof
#196Polyamine-fatty acid derived lipidoids and uses thereof
#197Quaternary ammonium hydroxides
#198Prodrugs of monomethyl fumarate (MMF)
#199Preparation of dihydroxyethyl piperazine
#200TREATMENT OF MULTIPLE SCLEROSIS AND PSORIASIS USING PRODRUGS OF METHYL HYDROGEN FUMARATE
#201BAX agonist, compositions, and methods related thereto
#202Alpha hydroxy amides
#203Immunomodulatory compounds
#204Post-synthetic chemical modification of RNA at the 2′-position of the ribose ring via “click” chemistry
#205Chiral control
#206Compounds and methods for treating mammalian gastrointestinal microbial infections
#207Dye composition comprising a cationic O-alkyl-substituted meta-phenylenediamine derivative
#208Oligomer-Antihistamine Conjugates
#209Treprostinil derivative compounds and methods of using same
#210Phenoxypropanol derivative and pharmaceutical composition including the same
#211Reactive ionic liquids
#212Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
#213Indanyloxyphenylcyclopropanecarboxylic acids
#214Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
#215Modulators of the relaxin receptor 1
#216Method of modulating ribonucleotide reductase
#217Photoactivatable caged tamoxifen and tamoxifen derivative molecules and methods of use thereof
#218Estrogen receptor ligands and methods of use thereof
#219Compounds
#220Aryl derivatives and uses thereof
#221Compounds, compositions, and methods for modulating ferroptosis and treating excitotoxic disorders
#222Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#223CINNAMIC ACID HYDROXYAMIDES AS INHIBITORS OF HISTONE DEACETYLASE 8
#224Bisarylsulfonamides useful in the treatment of inflammation and cancer
#225Pharmaceutical composition for preventing or treating cognitive impairment-related disease comprising morpholine or piperazine based compounds, and donepezil
#226Fluorescent pI markers for isoelectric focusing separations and fluorescent labeling
#227Menin-MLL inhibitors and methods of use thereof
#228Therapeutic compounds
#229Aniline derivatives, their preparation and their therapeutic application
#230Modifying Polymeric Materials By Amines
#231METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
#232N-adamantyl benzamides as inhibitors of 11-β-hydroxysteroid dehydrogenase
#233PLATINUM COMPOUNDS THAT INHIBIT CONSTITUTIVE STAT3 SIGNALING AND INDUCE CELL CYCLE ARREST AND APOPTOSIS OF MALIGNANT CELLS
#234Ionic liquids, the method for preparing the same and method for removing acetylenes from olefin mixtures using the ionic liquids
#235L-setastine hydrochloride and preparation method thereof
#236Prodrugs of fumarates and their use in treating various diseases
#237Process for making alkoxylated piperazine compounds
#238Treprostinil derivative compounds and methods of using same
#239Tropolone compounds for treating or preventing retroviral infection
#240Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
#241Tetra--substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use
#242BAX agonist, compositions, and methods related thereto
#243Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance
#244NEW CRYSTALLINE FORM OF CLOPERASTINE HYDROCHLORIDE
#245Aryl derivatives and uses thereof
#246Modulators of cortical dopaminergic- and NMDA-receptor-mediated glutamatergic neurotransmission
#247METHODS AND COMPOSITIONS FOR TREATING AMYLOID-RELATED DISEASES
#248Histone Deacetylase Inhibitors for Enhancing Activity of Antifungal Agents
#249ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF
#250Morpholinoalkyl Fumarate Compounds, Pharmaceutical Compositions, and Methods of Use
#251NMDA receptor antagonists for neuroprotection
#252Method of inhibiting tau phosphorylation
#253Process for the preparation of a mono-N-alkypiperazine
#254Process for the preparation of a mono-N-alkylpiperazine
#255Treatment of Multiple Sclerosis and Psoriasis Using Prodrugs of Methyl Hydrogen Fumarate
#256Tetra-substituted NDGA derivatives via ether bonds and carbamate bonds and their synthesis and pharmaceutical use
#257Organic amine salts of Azilsartan, preparation method and use thereof
#2581-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
#259Quaternary ammonium hydroxides
#260Aryloxy phenoxy acrylic compound having HIF-1 inhibition activity, method for preparing same, and pharmaceutical composition containing same as an active ingredient
#261N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
#262Bridged Spiro[2.4]heptane ester derivatives
#263Ionic liquid, lithium secondary battery electrolyte comprising the ionic liquid, and lithium secondary battery comprising the electrolyte
#264Morpholinoalkyl fumarate compounds, pharmaceutical compositions, and methods of use
#265Cationic alcohols and uses thereof
#266Indane estrogen receptor modulators and uses thereof
#267Functionally selective ligands of dopamine Dreceptors
#268AMINE SULFIDE SCAVENGERS, METHODS OF USING, AND METHODS OF MAKING
#269C7-fluoro substituted tetracycline compounds
#270Cationic lipids for oligonucleotide delivery
#271OLIGOMER-ANTIHISTAMINE CONJUGATES
#272Tetra-O-substituted butane-bridge modified NDGA derivatives, their synthesis and pharmaceutical use
#273Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
#274Copper plating bath containing a tertiary amine compound and use thereof
#275Biological buffers with wide buffering ranges
#276C7-fluoro substituted tetracycline compounds
#277Monohydrochloride salt of 1-[3-[3-(4-chlorophenyl) propoxy]propyl]-piperidine
#278Cationic alcohols and uses thereof
#279Biological buffers with wide buffering ranges
#280Inhibitors of sphingosine kinase
#281Indenone derivative and pharmaceutical composition comprising same
#282Compounds, pharmaceutical compositions and uses thereof
#283Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process
#2842-adamantylurea derivatives as selective 11β-HSD1 inhibitors
#285Alpha-arylmethoxyacrylate derivative, preparation method thereof, and pharmaceutical composition containing same
#286Buffer compounds
#287N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation
#288Dibenzocycloheptatone derivatives and pharmaceutical agents containing said compounds
#289Process for preparing 1,4-bishydroxyethylpiperazine
#290VASOPRESSIN V1A ANTAGONISTS
#291CALCIUM-SENSING RECEPTOR-ACTIVE COMPOUNDS
#292Ionic liquids, the method for preparing the same and method for removing acetylenes from olefin mixtures using the ionic liquids
#293PROCESS FOR PREPARING (METH)ACRYLIC ESTERS OF N,N-SUBSTITUTED AMINO ALCOHOLS
#294DIALKYLAMINO ALKYL ESTERS OF PIVAGABINE AS MEDICAMENTS FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS
#295Low viscosity ionic liquids
#296Derivatives of N-(arylamino)sulfonamides as inhibitors of MEK
#297Method and compositions for treating amyloid-related diseases
#298Selective estrogen receptor modulator
#299NOVEL SOLID STATE FORMS OF RANOLAZINE SALTS
#300Substituted phenylpiperazinyl aralkylalcohol derivatives, pharmaceutical compositions containing such derivatives and uses thereof